Clinical Trial Update: Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a phase 1/2 study evaluating human umbilical cord-derived mesenchymal stem cells for ischemic cardiomyopathy. The current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy (mesenchymal stem cells (umbilical cord-derived))

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Chronic Ischemic Heart Disease, Heart Failure | Phase 1, Phase 2 | Status: UNKNOWN